From Siloed Methods to Integrated Pipelines: Coupled Approaches Driving Next-Generation Antibiotic Discovery
Authors:
- Areej M. AlajmiAAAreej M. Alajmi
- Abdullah A. AlshehriAAAbdullah A. Alshehri
- Nojoud Al FayezNFNojoud Al Fayez
- Fahad A. AlmughemFAFahad A. Almughem
- Haila M. AlnassarHAHaila M. Alnassar
- Hamzah A. AlghamdiHAHamzah A. Alghamdi
- Manal A. AlshabibiMAManal A. Alshabibi
- Abdulkareem A. AlshehriAAAbdulkareem A. Alshehri
- Shouq F. AlghannamSAShouq F. Alghannam
- Esraa A. AldkheilEAEsraa A. Aldkheil
- Hissah A. AlhuwaimelHAHissah A. Alhuwaimel
- Zeyad AlRaddadiZAZeyad AlRaddadi
Open Access
- 28 October 2026
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 16 (11) , 1573
Abstract
Antibiotic resistance poses a growing threat to public health, yet limited innovation and development of new antibacterial agents continue to hinder antibiotic discovery. Although only a few novel antibiotic candidates have passed clinical trials and reached the market, resistance continues to grow faster than antibiotic development. Despite numerous advances in drug development, using these technologies in isolation has constrained antibiotic discovery. This review examines how advanced technologies integrate into antibiotic drug discovery. It highlights a coupled approach (co-applied technologies) as an innovative strategy to mitigate the limitations of single approaches and accelerate lead discovery. By highlighting each technology and reviewing its potential applications, this strategy opens new routes and methods that can yield novel chemical scaffolds and new mechanisms of action (i.e., weakening microbial resistance), addressing the challenges posed by increasing global resistance and shortcomings in current antibiotic development. The review also addresses the challenges and barriers to discovering next-generation antibiotics. It also encourages researchers to implement platforms that combine coupled approaches and technologies, such as computational, genomic, biochemical, and structural tools, to replenish the next-generation antibiotic discovery pipeline and address the antimicrobial resistance (AMR) crisis. To strengthen global efforts and lessen the AMR crisis, an innovative antibiotic discovery strategy is necessary.Keywords
This publication has 154 references indexed in Scilit:
- Artificial intelligence in protein-based detection and inhibition of AMR pathwaysJournal of Computer-Aided Molecular Design, 2025
- AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisionsClinical and Experimental Medicine, 2025
- Advancements in Molecular Property Prediction: A Survey of Single and Multimodal ApproachesArchives of Computational Methods in Engineering, 2025
- The role of genomics and proteomics in drug discovery and its application in pharmacyDiscover Applied Sciences, 2025
- Investigational antibiotic cefepime/zidebactam as a therapeutic option for the treatment of an unyielding empyema in a paediatric patient caused by extensively drug-resistant Pseudomonas aeruginosa: a case reportEuropean Journal of Clinical Microbiology & Infectious Diseases, 2025
- The applications and advances of artificial intelligence in drug regulation: A global perspectiveActa Pharmaceutica Sinica B, 2024
- Improving droplet microfluidic systems for studying single bacteria growthAnalytical and Bioanalytical Chemistry, 2022
- Antibiotic resistance: The challenges and some emerging strategies for tackling a global menaceJournal of Clinical Laboratory Analysis, 2022
- Phenotypic screening of compound libraries as a platform for the identification of antibiotic adjuvants: Identification of colistin adjuvants from a natural product library2022
- A Cascaded Droplet Microfluidic Platform Enables High‐Throughput Single Cell Antibiotic Susceptibility Testing at ScaleSmall Methods, 2021